Johnson & Johnson Financial Statements (JNJ)
|
|
|
|
Report date
|
|
|
17.02.2022 |
16.02.2023 |
16.02.2024 |
13.02.2025 |
11.02.2026 |
|
22.04.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
78 740 |
79 990 |
85 159 |
88 821 |
94 193 |
|
96 362 |
|
Operating Income, bln rub |
|
|
20 943 |
21 013 |
23 409 |
22 149 |
25 596 |
|
25 892 |
|
EBITDA, bln rub |
? |
|
26 751 |
26 605 |
23 320 |
24 781 |
41 055 |
|
31 616 |
|
Net profit, bln rub |
? |
|
20 878 |
17 941 |
35 153 |
14 066 |
26 804 |
|
21 040 |
|
|
OCF, bln rub |
? |
|
23 410 |
21 194 |
22 791 |
24 266 |
24 530 |
|
22 870 |
|
CAPEX, bln rub |
? |
|
3 652 |
4 009 |
4 543 |
4 424 |
4 832 |
|
5 072 |
|
FCF, bln rub |
? |
|
19 758 |
17 185 |
18 248 |
19 842 |
19 698 |
|
17 798 |
|
Dividend payout, bln rub
|
|
|
11 032 |
11 682 |
11 770 |
11 823 |
12 381 |
|
12 523 |
|
|
Ordinary share dividend yield, %
|
|
|
|
|
|
|
|
|
0.00% |
|
Dividend payout ratio, %
|
|
|
52.8% |
65.1% |
33.5% |
84.1% |
46.2% |
|
59.5% |
|
|
OPEX, bln rub |
|
|
34 395 |
34 381 |
35 197 |
39 201 |
42 962 |
|
40 712 |
|
Cost of production, bln rub |
|
|
23 402 |
24 596 |
26 553 |
27 471 |
25 635 |
|
29 758 |
|
R&D, bln rub |
|
|
14 277 |
14 135 |
15 085 |
17 232 |
14 665 |
|
14 967 |
|
Interest expenses, bln rub |
|
|
183.0 |
276.0 |
772.0 |
755.0 |
971.0 |
|
810.0 |
|
|
Assets, bln rub |
|
|
182 018 |
187 378 |
167 558 |
180 104 |
199 210 |
|
200 894 |
|
Net Assets, bln rub |
? |
|
74 023 |
76 804 |
68 774 |
71 490 |
81 544 |
|
81 186 |
|
Debt, bln rub |
|
|
33 751 |
39 642 |
29 332 |
36 634 |
47 933 |
|
17 460 |
|
Cash, bln rub |
|
|
31 608 |
22 281 |
22 927 |
24 522 |
20 102 |
|
22 051 |
|
Net debt, bln rub |
|
|
2 143 |
17 361 |
6 405 |
12 112 |
27 831 |
|
-4 591 |
|
|
Ordinary share price, rub |
|
|
|
|
|
|
|
|
232.8 |
|
Number of ordinary shares, mln |
|
|
2 629 |
2 614 |
2 534 |
2 407 |
2 429 |
|
2 445 |
|
|
Market cap, bln rub |
|
|
0 |
0 |
0 |
0 |
0 |
|
569 165 |
|
EV, bln rub |
? |
|
2 143 |
17 361 |
6 405 |
12 112 |
27 831 |
|
564 574 |
|
Book value, bln rub |
|
|
-7 615 |
2 268 |
-1 959 |
-10 328 |
-17 631 |
|
-16 433 |
|
|
EPS, rub |
? |
|
7.94 |
6.86 |
13.9 |
5.84 |
11.0 |
|
8.60 |
|
FCF/share, rub |
|
|
7.52 |
6.58 |
7.20 |
8.24 |
8.11 |
|
7.28 |
|
BV/share, rub |
|
|
-2.90 |
0.87 |
-0.77 |
-4.29 |
-7.26 |
|
-6.72 |
|
|
EBITDA margin, % |
? |
|
34.0% |
33.3% |
27.4% |
27.9% |
43.6% |
|
32.8% |
|
Net margin, % |
? |
|
26.5% |
22.4% |
41.3% |
15.8% |
28.5% |
|
21.8% |
|
FCF yield, % |
? |
|
|
|
|
|
|
|
3.13% |
|
ROE, % |
? |
|
28.2% |
23.4% |
51.1% |
19.7% |
32.9% |
|
25.9% |
|
ROA, % |
? |
|
11.5% |
9.57% |
21.0% |
7.81% |
13.5% |
|
10.5% |
|
|
P/E |
? |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
27.1 |
|
P/FCF |
|
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
32.0 |
|
P/S |
? |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
5.91 |
|
P/BV |
? |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
-34.6 |
|
EV/EBITDA |
? |
|
0.08 |
0.65 |
0.27 |
0.49 |
0.68 |
|
17.9 |
|
Debt/EBITDA |
|
|
0.08 |
0.65 |
0.27 |
0.49 |
0.68 |
|
-0.15 |
|
|
R&D/CAPEX, % |
|
|
390.9% |
352.6% |
332.0% |
389.5% |
303.5% |
|
295.1% |
|
|
CAPEX/Revenue, % |
|
|
4.64% |
5.01% |
5.33% |
4.98% |
5.13% |
|
5.26% |
|
| Johnson & Johnson shareholders |
